Cargando…
A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma
Background: Glioma has the highest fatality rate among intracranial tumours. Besides, the heterogeneity of gliomas leads to different therapeutic effects even with the same treatment. Developing a new signature for glioma to achieve the concept of “personalised medicine” remains a significant challe...
Autores principales: | Zhong, Jiasheng, Liu, Jie, Huang, Zhilin, Zheng, Yaofeng, Chen, Jiawen, Ji, Jingsen, Chen, Taoliang, Ke, Yiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637659/ https://www.ncbi.nlm.nih.gov/pubmed/36353102 http://dx.doi.org/10.3389/fgene.2022.1026192 |
Ejemplares similares
-
Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022) -
Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021) -
Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas
por: Feng, Xiaoqiang, et al.
Publicado: (2022) -
A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction
por: Zheng, Pengxiang, et al.
Publicado: (2023) -
Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia
por: Zhong, Guangcai, et al.
Publicado: (2023)